Tango Therapeutics, Inc.
Ticker: 1819133
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 | Q3 FY23 | Q2 FY23 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 53.81+1592.1% | 3.18-41.0% | 5.39-53.6% | 11.61-41.6% | 19.88+207.3% | 6.47-39.7% | 10.73-26.5% | 14.60 |
| Total Income | 53.81+1592.1% | 3.18-41.0% | 5.39-53.6% | 11.61-41.6% | 19.88+207.3% | 6.47-39.7% | 10.73-26.5% | 14.60 |
| EXPENSES | ||||||||
| Expenditure | 39.74-10.0% | 44.15-7.9% | 47.92+7.7% | 44.49-10.0% | 49.43+1.4% | 48.73+34.0% | 36.36-3.9% | 37.85 |
| Tax | -0.01-125.0% | 0.04+33.3% | 0.03-40.0% | 0.05-28.6% | 0.07+75.0% | 0.04+100.0% | 0.02-66.7% | 0.06 |
| PROFIT | ||||||||
| PBT | 15.87+140.9% | -38.82+2.6% | -39.84-36.9% | -29.11-14.2% | -25.49+32.7% | -37.87-70.3% | -22.24-7.7% | -20.65 |
| Net Profit | 15.88+140.9% | -38.85+2.6% | -39.88-36.7% | -29.17-14.2% | -25.55+32.6% | -37.91-70.3% | -22.26-7.5% | -20.71 |
| KEY METRICS | ||||||||
| OPM % | 26.15%+126.15pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | 29.52%+129.52pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | 0.14+140.0% | -0.35+2.8% | -0.36-33.3% | -0.27-12.5% | -0.24+31.4% | -0.35-52.2% | -0.23+0.0% | -0.23 |
Corporate Events
Board MeetingTNGX
20263Aug
Board Meeting
Dr. Barbara Weber's employment as Executive Chair and board …
SEC Filing ↗ Board MeetingTNGX
202619Jun
Board Meeting
Appointment of Robert Azelby to the Board of Directors and i…
SEC Filing ↗ Board MeetingTNGX
20264Jun
Board Meeting
Annual Meeting of Stockholders to elect Class II directors, …
SEC Filing ↗ Board MeetingTNGX
202613May
Board Meeting
Alexis Borisy and Kanishka Pothula resigned from the Board o…
SEC Filing ↗ Board MeetingTNGX
202615Apr
Board Meeting
Officer Transition at Tango Therapeutics, Inc. — A financial…
SEC Filing ↗